Leukocytosis after Clozapine Treatment in a Patient with Chronic Schizophrenia

---

Copy For Citation

Polat A. Ö., Cakir U., Gunduz N.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, vol.53, no.1, pp.87-88, 2016 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 53 Issue: 1
• Publication Date: 2016
• Doi Number: 10.5152/npa.2015.9855
• Journal Name: NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
• Page Numbers: pp.87-88
• Kocaeli University Affiliated: Yes

Abstract

Clozapine is an atypical antipsychotic drug that is approved by the US Food and Drug Administration (FDA) for the treatment of psychotic disorders. Agranulocytosis is a well-established side effect of clozapine; clozapine has also been associated with other blood dyscrasias like leukocytosis, albeit rarely. In this paper, we aim to report a case of possible clozapine-associated leukocytosis in a 41-year-old woman.